annual cash & cash equivalents:
$189.82M+$154.05M(+430.56%)Summary
- As of today (September 18, 2025), CDTX annual cash & cash equivalents is $189.82 million, with the most recent change of +$154.05 million (+430.56%) on December 31, 2024.
- During the last 3 years, CDTX annual cash & cash equivalents has risen by +$130.15 million (+218.07%).
- CDTX annual cash & cash equivalents is now at all-time high.
Performance
CDTX Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$516.91M+$342.42M(+196.24%)Summary
- As of today (September 18, 2025), CDTX quarterly cash & cash equivalents is $516.91 million, with the most recent change of +$342.42 million (+196.24%) on June 30, 2025.
- Over the past year, CDTX quarterly cash & cash equivalents has increased by +$352.54 million (+214.48%).
- CDTX quarterly cash & cash equivalents is now at all-time high.
Performance
CDTX quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CDTX Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +430.6% | +214.5% |
| 3 y3 years | +218.1% | +1967.1% |
| 5 y5 years | +277.6% | +706.6% |
CDTX Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +479.9% | at high | +1967.1% |
| 5 y | 5-year | at high | +479.9% | at high | +1967.1% |
| alltime | all time | at high | >+9999.0% | at high | +2167.6% |
CDTX Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $516.91M(+196.2%) |
| Mar 2025 | - | $174.49M(-11.1%) |
| Dec 2024 | $189.82M(+430.6%) | $196.18M(+54.0%) |
| Sep 2024 | - | $127.39M(-22.5%) |
| Jun 2024 | - | $164.37M(+466.4%) |
| Mar 2024 | - | $29.02M(-18.9%) |
| Dec 2023 | $35.78M(+9.3%) | $35.78M(-26.5%) |
| Sep 2023 | - | $48.67M(-3.5%) |
| Jun 2023 | - | $50.43M(+5.1%) |
| Mar 2023 | - | $47.98M(+46.6%) |
| Dec 2022 | $32.73M(-45.2%) | $32.73M(-38.3%) |
| Sep 2022 | - | $53.08M(+112.3%) |
| Jun 2022 | - | $25.01M(-34.1%) |
| Mar 2022 | - | $37.97M(-39.0%) |
| Dec 2021 | $59.68M(+66.2%) | $62.27M(+54.5%) |
| Sep 2021 | - | $40.30M(-24.1%) |
| Jun 2021 | - | $53.10M(+8.8%) |
| Mar 2021 | - | $48.79M(+13.6%) |
| Dec 2020 | $35.91M(-28.6%) | $42.95M(-20.0%) |
| Sep 2020 | - | $53.67M(-16.3%) |
| Jun 2020 | - | $64.08M(-13.8%) |
| Mar 2020 | - | $74.31M(+23.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $50.27M(-32.6%) | $60.27M(-18.4%) |
| Sep 2019 | - | $73.82M(+65.6%) |
| Jun 2019 | - | $44.57M(-22.4%) |
| Mar 2019 | - | $57.41M(-23.0%) |
| Dec 2018 | $74.56M(+22.6%) | $74.56M(-15.5%) |
| Sep 2018 | - | $88.27M(-14.5%) |
| Jun 2018 | - | $103.20M(+54.1%) |
| Mar 2018 | - | $66.98M(-11.1%) |
| Dec 2017 | $60.81M(-28.8%) | $75.31M(+17.4%) |
| Sep 2017 | - | $64.15M(-17.8%) |
| Jun 2017 | - | $78.01M(-13.4%) |
| Mar 2017 | - | $90.09M(-13.9%) |
| Dec 2016 | $85.37M(+36.5%) | $104.62M(+31.9%) |
| Sep 2016 | - | $79.31M(-8.9%) |
| Jun 2016 | - | $87.09M(-9.9%) |
| Mar 2016 | - | $96.66M(-10.1%) |
| Dec 2015 | $62.56M(+174.4%) | $107.51M(-6.0%) |
| Sep 2015 | - | $114.42M(-6.4%) |
| Jun 2015 | - | $122.30M(+110.4%) |
| Mar 2015 | - | $58.12M(+155.0%) |
| Dec 2014 | $22.80M(>+9900.0%) | $22.80M |
| Dec 2013 | $185.00K | - |
FAQ
- What is Cidara Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Cidara Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of CDTX is $189.82M
What is the all time high annual cash & cash equivalents for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual cash & cash equivalents is $189.82M
What is Cidara Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, CDTX annual cash & cash equivalents has changed by +$154.05M (+430.56%)
What is Cidara Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CDTX is $516.91M
What is the all time high quarterly cash & cash equivalents for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $516.91M
What is Cidara Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, CDTX quarterly cash & cash equivalents has changed by +$352.54M (+214.48%)